Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Iatreia
Print version ISSN 0121-0793
Abstract
GARCIA-MONTOYA, Andrés José and BARRERA-ESCOBAR, Sebastián. Acute kidney injury and hemolytic anemia induced by rifampin, an infrequent and deadly complication. Iatreia [online]. 2022, vol.35, n.3, pp.356-360. Epub May 19, 2023. ISSN 0121-0793. https://doi.org/10.17533/udea.iatreia.145.
Rifampicin is a widely used drug for the treatment of various infectious diseases with a broad spectrum of adverse reaction ranging from mild to life-threatening manifestations; hemolytic anemia is an adverse effect rarely reported in the literature, but it can have a potentially fatal outcome. Thus, we report a case of autoimmune hemolytic anemia associated with acute kidney injury in a young patient in the second phase of treatment for pulmonary tuberculosis.
Keywords : Acute Kidney Injury; Hemolysis; Rifampin.